A rapid chemiluminescence immunoassay for plasmin-α2 antiplasmin complex utilizing novel monoclonal antibodies
Abstract
= 0.99), alongside enhanced sensitivity and specificity, as evidenced by an area under the curve (AUC) of 0.95 compared to 0.90. In summary, we have developed a rapid, high-performance PIC detection platform based on novel monoclonal antibodies. This platform is compatible with point-of-care testing (POCT) and represents a highly promising and reliable tool for the clinical assessment of hyperfibrinolysis.
Fields of Study & Subjects
Protease and Inhibitor Mechanisms
Blood properties and coagulation
Advanced Biosensing Techniques and Applications
Publication details
- Journal / source
- Analytical Methods
- Publisher
- Royal Society of Chemistry (RSC)
- Volume
- 18
- Issue
- 14
- Pages
- 2872–2885
- Publication date
- 1 January 2026
- Language
- EN